Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261,276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis.
Li JY, Huang CL, Luo WJ, Zhang Y, Tang LL, Peng H, Sun Y, Chen YP, Ma J. Li JY, et al. Among authors: zhang y. Ther Adv Med Oncol. 2019 Sep 25;11:1758835919877729. doi: 10.1177/1758835919877729. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31598143 Free PMC article.
Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006-2016.
Xu C, Zhang Y, Chen L, Li WF, Tang SQ, Tang LL, Guo Y, Liu Q, Lin AH, Sun Y, Ma J. Xu C, et al. Among authors: zhang y. Radiother Oncol. 2020 Oct;151:306-313. doi: 10.1016/j.radonc.2020.08.019. Epub 2020 Aug 29. Radiother Oncol. 2020. PMID: 32866562 Free article.
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
Lei Y, Li YQ, Jiang W, Hong XH, Ge WX, Zhang Y, Hu WH, Wang YQ, Liang YL, Li JY, Cho WCS, Yun JP, Zeng J, Chen JW, Liu LZ, Li L, Chen L, Xie FY, Li WF, Mao YP, Liu X, Chen YP, Tang LL, Sun Y, Liu N, Ma J. Lei Y, et al. Among authors: zhang y. J Natl Cancer Inst. 2021 Apr 6;113(4):471-480. doi: 10.1093/jnci/djaa100. J Natl Cancer Inst. 2021. PMID: 33094348 Free PMC article.
The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients.
Tang SQ, Tang LL, Mao YP, Li WF, Chen L, Zhang Y, Guo Y, Liu Q, Sun Y, Xu C, Ma J. Tang SQ, et al. Among authors: zhang y. Cancer Res Treat. 2021 Apr;53(2):339-354. doi: 10.4143/crt.2020.790. Epub 2020 Nov 6. Cancer Res Treat. 2021. PMID: 33171025 Free PMC article. Clinical Trial.
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Chen YP, Lv JW, Mao YP, Li XM, Li JY, Wang YQ, Xu C, Li YQ, He QM, Yang XJ, Lei Y, Shen JY, Tang LL, Chen L, Zhou GQ, Li WF, Du XJ, Guo R, Liu X, Zhang Y, Zeng J, Yun JP, Sun Y, Liu N, Ma J. Chen YP, et al. Among authors: zhang y. Mol Cancer. 2021 Jan 11;20(1):14. doi: 10.1186/s12943-020-01292-5. Mol Cancer. 2021. PMID: 33430876 Free PMC article.
261,276 results
You have reached the last available page of results. Please see the User Guide for more information.